demonstrated that GLP1-R activation leads to a modest but statistically significant increase in cAMP concentration in mixed leucocyte populations, including Tregs ( Figure 1 )
No other GLP-1 medication has come close to this level of liver fat clearance
These substances are processed by the body through different pathways and do not interfere with each other's absorption, metabolism, or effectiveness
Like I said, appreciate you, appreciate you taking the time with us today
On April 29, 2025, a press release hailed the Novo Nordisk tie-up for "affordable access" to semaglutide, calling it "high-quality" and "personalized." Dudum said it tackled shortages while "prioritizing safety." The Q1 earnings call echoed this, with Dudum bragging about "innovative partnerships" for consumer choice